You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Do we want to actually implement a reviewing process for module proposal? -> NO, discussions are enough.
What do we want to discuss regarding DDA quant module in the paper?
different versions of the same tool do not output the same results
same tools same version can output different results due to a random step (MQ)
MBR increases coverage (detection across replicate runs) with a cost: reduced accuracy
2nd peptide search with MQ?
there is kind of a linear trend: higher sensitivity ~ loss of ratio accuracy
What parameter sets/tools are missing?
Do we want to dig deeper (look back at the raw/intermediate files) and if yes -> what do we want to investigate?
check public data sets in the DDA quant module. Are these correct? (I have doubts on the FragPipe outputs, I may have messed up there)
check what tools we are compatible with in the DDA quant module. Decide how we want to handle Proline (there are many different outputs due to the flexibility of the tool) (see Full support all software ion module #346)
Do we want to discuss the peptidoform module? (I think that it would be nice to advertise WOMBAT-P and see if the results are different from the DDA quant module).
What do we want to discuss regarding the DIA module?
To do:
The text was updated successfully, but these errors were encountered: